MedAngel is a forward-thinking digital health firm based in The Netherlands, dedicated to enhancing the lives of patients who use temperature-sensitive medications. Founded in 2015, the company has successfully merged the healthcare and technology industries with its flagship product, MedAngelONE.
The innovative product consists of a small sensor and an accompanying smartphone app designed to empower patients by offering an effortless way to monitor the temperature of their essential medications. This dual approach not only addresses the daily challenges users face but also strengthens cold chain management, ensuring safety and security in medication usage.
With its last known financial backing being a Seed Round investment on 29 March 2016, supported by Rockstart Accelerator, MedAngel shows potential for impactful growth in the nexus of Health Care, IT, and Autonomous and Sensor Tech. This positions the company strategically for investors looking to be part of the digital health revolution.